Cancer Research SABCS  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schimmer, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schimmer, A. D.
Related Collections
Right arrow Therapeutics and Targets
Right arrow Therapeutics and Targets: Identification, Validation, and Markers
[Cancer Research 64, 7183-7190, October 15, 2004]
© 2004 American Association for Cancer Research


Review

Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice

Aaron D. Schimmer

Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

The inhibitor of apoptosis proteins (IAPs) are a family of antiapoptotic proteins that bind and inhibit caspases 3, 7, and/or 9, but not caspase 8. Growing evidence also indicates that IAPs also modulate cell division, cell cycle progression, and signal transduction pathways. As our basic understanding of IAPs has increased, the knowledge is being translated into clinically useful applications in the diagnosis and treatment of malignancy. For example, IAPs such as survivin are being investigated as diagnostic markers for the presence of occult malignancy. In addition, IAP overexpression is a poor prognostic marker in a variety of solid tumors and hematologic malignancies. Finally, IAPs are attractive therapeutic targets, and efforts are under way to develop antisense and chemical IAP inhibitors that may be useful for the treatment of a variety of malignancies. For all of these potential clinical applications, however, the challenge remains to incorporate these findings into actual clinical practice.




This article has been cited by other articles:


Home page
Hum ReprodHome page
A. Watanabe, F. Taniguchi, M. Izawa, K. Suou, T. Uegaki, E. Takai, N. Terakawa, and T. Harada
The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis
Hum. Reprod., September 3, 2009; (2009) dep305v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-C. Shen, F.-C. Hu, Y.-M. Jeng, Y.-T. Chang, Z.-Z. Lin, M.-C. Chang, C. Hsu, and A.-L. Cheng
Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival
Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Wang, Q. Zhang, B. Liu, M. Han, and B. Shan
Challenge and promise: roles for Livin in progression and therapy of cancer
Mol. Cancer Ther., December 1, 2008; 7(12): 3661 - 3669.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Dai, M. Liu, W. Tang, J. DeSano, E. Burstein, M. Davis, K. Pienta, T. Lawrence, and L. Xu
Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis
Clin. Cancer Res., December 1, 2008; 14(23): 7701 - 7710.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Jiang, W. Nishimura, D. Devor-Henneman, D. Kusewitt, H. Wang, M. P. Holloway, T. Dohi, E. Sabo, M. L. Robinson, D. C. Altieri, et al.
Postnatal Expansion of the Pancreatic {beta}-Cell Mass Is Dependent on Survivin
Diabetes, October 1, 2008; 57(10): 2718 - 2727.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. C. Mita, M. M. Mita, S. T. Nawrocki, and F. J. Giles
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
Clin. Cancer Res., August 15, 2008; 14(16): 5000 - 5005.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
S. H. Cho, S. H. Lee, K. R. Kim, H. M. Lee, S. H. Lee, and T. H. Kim
Expression and Distributional Patterns of the Inhibitor of Apoptosis Protein Family and Caspase 3 in Nasal Polyps
Arch Otolaryngol Head Neck Surg, March 1, 2008; 134(3): 316 - 321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Lechler, X. Wu, W. Bernhardt, V. Campean, S. Gastiger, T. Hackenbeck, B. Klanke, A. Weidemann, C. Warnecke, K. Amann, et al.
The Tumor Gene Survivin Is Highly Expressed in Adult Renal Tubular Cells: Implications for a Pathophysiological Role in the Kidney
Am. J. Pathol., November 1, 2007; 171(5): 1483 - 1498.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Vucic and W. J. Fairbrother
The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer
Clin. Cancer Res., October 15, 2007; 13(20): 5995 - 6000.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. B. Seligson, F. Hongo, S. Huerta-Yepez, Y. Mizutani, T. Miki, H. Yu, S. Horvath, D. Chia, L. Goodglick, and B. Bonavida
Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer Recurrence
Clin. Cancer Res., October 15, 2007; 13(20): 6056 - 6063.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. A. Mawji, C. D. Simpson, M. Gronda, M. A. Williams, R. Hurren, C. J. Henderson, A. Datti, J. L. Wrana, and A. D. Schimmer
A Chemical Screen Identifies Anisomycin as an Anoikis Sensitizer That Functions by Decreasing FLIP Protein Synthesis
Cancer Res., September 1, 2007; 67(17): 8307 - 8315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ashare, M. M. Monick, A. B. Nymon, J. M. Morrison, M. Noble, L. S. Powers, T. O. Yarovinsky, T. L. Yahr, and G. W. Hunninghake
Pseudomonas aeruginosa Delays Kupffer Cell Death via Stabilization of the X-Chromosome-Linked Inhibitor of Apoptosis Protein
J. Immunol., July 1, 2007; 179(1): 505 - 513.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S. Elmore
Apoptosis: A Review of Programmed Cell Death
Toxicol Pathol, June 1, 2007; 35(4): 495 - 516.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
I. A. Mawji, C. D. Simpson, R. Hurren, M. Gronda, M. A. Williams, J. Filmus, J. Jonkman, R. S. Da Costa, B. C. Wilson, M. P. Thomas, et al.
Critical Role for Fas-Associated Death Domain-Like Interleukin-1-Converting Enzyme-Like Inhibitory Protein in Anoikis Resistance and Distant Tumor Formation
J Natl Cancer Inst, May 16, 2007; 99(10): 811 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Sasaki, N. Ohara, Q. Xu, J. Wang, D. A. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
A Novel Selective Progesterone Receptor Modulator Asoprisnil Activates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Signaling Pathway in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 616 - 623.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Choi, Y. K. Hwang, K. W. Sung, S. H. Lee, K. H. Yoo, H. L. Jung, H. H. Koo, H.-J. Kim, H. J. Kang, H. Y. Shin, et al.
Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia
Blood, January 15, 2007; 109(2): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Chang and A. D. Schimmer
Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy
Mol. Cancer Ther., January 1, 2007; 6(1): 24 - 30.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Y. Lim, Y. Jeong, A. L. Tyner, and J. H. Y. Park
Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin
Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G66 - G75.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Mateo-Lozano, P. C. Gokhale, V. A. Soldatenkov, A. Dritschilo, O. M. Tirado, and V. Notario
Combined Transcriptional and Translational Targeting of EWS/FLI-1 in Ewing's Sarcoma.
Clin. Cancer Res., November 15, 2006; 12(22): 6781 - 6790.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. J. Braeuer, C. Buneker, A. Mohr, and R. M. Zwacka
Constitutively Activated Nuclear Factor-{kappa}B, but not Induced NF-{kappa}B, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells
Mol. Cancer Res., October 1, 2006; 4(10): 715 - 728.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. J. Reu, S. I. Bae, L. Cherkassky, D. W. Leaman, D. Lindner, N. Beaulieu, A. R. MacLeod, and E. C. Borden
Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation
J. Clin. Oncol., August 10, 2006; 24(23): 3771 - 3779.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. A. Emamaullee and A.M. J. Shapiro
Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation.
Diabetes, July 1, 2006; 55(7): 1907 - 1914.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Waldele, K. Silbermann, G. Schneider, T. Ruckes, B. R. Cullen, and R. Grassmann
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes
Blood, June 1, 2006; 107(11): 4491 - 4499.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. A. Gomez, A. de las Pozas, and C. Perez-Stable
Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells
Mol. Cancer Ther., May 1, 2006; 5(5): 1216 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. R. Santos, M. Rodriguez-Pinilla, F. M. Vega, J. L. Rodriguez-Peralto, S. Blanco, A. Sevilla, A. Valbuena, T. Hernandez, A. J. van Wijnen, F. Li, et al.
VRK1 Signaling Pathway in the Context of the Proliferation Phenotype in Head and Neck Squamous Cell Carcinoma
Mol. Cancer Res., March 1, 2006; 4(3): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T Taguchi, T Takao, Y Iwasaki, M Nishiyama, K Asaba, and K Hashimoto
Suppressive effects of dehydroepiandrosterone and the nuclear factor-{kappa}B inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo
J. Endocrinol., February 1, 2006; 188(2): 321 - 331.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. R. Martin
Targeting Apoptosis with Dietary Bioactive Agents
Experimental Biology and Medicine, February 1, 2006; 231(2): 117 - 129.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Feng, P. Li, C. Salamanca, D. Huntsman, P. C.K. Leung, and N. Auersperg
Caspase-1{alpha} Is Down-regulated in Human Ovarian Cancer Cells and the Overexpression of Caspase-1{alpha} Induces Apoptosis
Cancer Res., October 1, 2005; 65(19): 8591 - 8596.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yang, C. Zhong, B. Frenkel, A. H. Reddi, and P. Roy-Burman
Diverse Biological Effect and Smad Signaling of Bone Morphogenetic Protein 7 in Prostate Tumor Cells
Cancer Res., July 1, 2005; 65(13): 5769 - 5777.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
A. D. Schimmer and S. Dalili
Targeting the IAP Family of Caspase Inhibitors as an Emerging Therapeutic Strategy
Hematology, January 1, 2005; 2005(1): 215 - 219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.